Chloe M. de Nys
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chloe M. de Nys has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Mark C. Allenby
University of Queensland
5 shared publications Craig D. Winter
Metro North Health, Herston Biofabrication Institute, Brisbane, Australia
3 shared publicationsAshley R. Murphy
School of Chemical Engineering The University of Queensland St Lucia Australia
2 shared publications- Ashley R. Murphy
School of Chemical Engineering, The University of Queensland, 46 Staff House Road, 4072, St Lucia, Australia
2 shared publications - Danilo Carluccio
Department of Oral and Maxillofacial Surgery, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Herston Biofabrication Institute, Metro North Health, Brisbane, Queensland, Australia; School of Dentistry, The University of Queensland, Brisbane, Queensland, Australia
2 shared publications James I. Novak
Metro North Health, Herston Biofabrication Institute, Brisbane, Australia
2 shared publications
Latest Publications
- Open Access
Marrow-mimicry MEW scaffolds recapitulate erythroblastic islands for high-density cRBC biomanufacturing
Biomanufactured cell therapies are delivering a step-change in modern medicine, but their high costs have prevented widespread adoption. Cultured red blood cells (cRBCs) are one type of cell therapy in clinical trials for off-the-shelf blood transfusion but remain limited by the exorbitant costs of manufacturing trillions of RBCs required for a blood transfusion. These costs could be mitigated if culture platforms could grow cells at higher density, like those found in the bone marrow, requiring less media and lower concentrations of expensive growth factors per cell. We engineered melt electrowritten (MEW) polycaprolactone (PCL) scaffolds in geometries which imitate marrow trabeculae structures and were then plasma-treated to enable peripheral blood mononuclear cells (PB MNC) attachment. PB MNC monocytes first adhered to the scaffold and rapidly differentiated into CD68 + macrophage-like cells. These macrophage-loaded scaffolds adhered CD71 + erythroblasts, which then grew from 10 to 25% between days 4 and 8 and produced CD235a + erythroid cells by day 20, under erythrogenic culture conditions. MEW PCL scaffolds in trabecular-like geometries had greater surface area, adhered more macrophages, and generated more erythroblasts than traditional MEW crosshatch geometries. The MEW scaffolds continuously released less-adherent cells to the supernatant, providing a 74% increase in supernatant cell numbers versus liquid suspension controls with identical cell seeding numbers and media volumes. High-cell-density scaffolds exhibited increased metabolism and endogenous production of self-supportive cytokines, which may offer cost-saving opportunities through future media optimisation. This study reports marrow trabeculae-mimetic MEW PCL designs capable of selectively adhering PB MN cells to develop macrophage-coated scaffolds, which provided physical and paracrine support for cRBC production. This high-cell-density culture platform may be useful for future cell therapy biomanufacturing protocols.
Open AccessMarrow-mimicry MEW scaffolds recapitulate erythroblastic islands for high-density cRBC biomanufacturing
Biomanufactured cell therapies are delivering a step-change in modern medicine, but their high costs have prevented widespread adoption. Cultured red blood cells (cRBCs) are one type of cell therapy in clinical trials for off-the-shelf blood transfusion but remain limited by the exorbitant costs of manufacturing trillions of RBCs required for a blood transfusion. These costs could be mitigated if culture platforms could grow cells at higher density, like those found in the bone marrow, requiring less media and lower concentrations of expensive growth factors per cell. We engineered melt electrowritten (MEW) polycaprolactone (PCL) scaffolds in geometries which imitate marrow trabeculae structures and were then plasma-treated to enable peripheral blood mononuclear cells (PB MNC) attachment. PB MNC monocytes first adhered to the scaffold and rapidly differentiated into CD68 + macrophage-like cells. These macrophage-loaded scaffolds adhered CD71 + erythroblasts, which then grew from 10 to 25% between days 4 and 8 and produced CD235a + erythroid cells by day 20, under erythrogenic culture conditions. MEW PCL scaffolds in trabecular-like geometries had greater surface area, adhered more macrophages, and generated more erythroblasts than traditional MEW crosshatch geometries. The MEW scaffolds continuously released less-adherent cells to the supernatant, providing a 74% increase in supernatant cell numbers versus liquid suspension controls with identical cell seeding numbers and media volumes. High-cell-density scaffolds exhibited increased metabolism and endogenous production of self-supportive cytokines, which may offer cost-saving opportunities through future media optimisation. This study reports marrow trabeculae-mimetic MEW PCL designs capable of selectively adhering PB MN cells to develop macrophage-coated scaffolds, which provided physical and paracrine support for cRBC production. This high-cell-density culture platform may be useful for future cell therapy biomanufacturing protocols.
- Open Access
Identifying cytokine-release signatures of flow-driven endothelial remodelling in an intracranial aneurysm cell culture model
Intracranial aneurysm (IA) rupture is catastrophic, yet current models of rupture-risk inadequately capture underlying IA remodelling mechanisms. Endothelial-haemodynamic interactions are central to these processes, but in vitro flow platforms often lack vessel-relevant geometry or long-term perfusion. Here, temporal and spatial endothelial responses to haemodynamic stress were investigated across idealised and patient-specific vascular models. Polydimethylsiloxane models were endothelialised with human aortic endothelial cells then perfused at up to 1.6 Pa wall shear stress for five days. IA models were exposed to steady or cardiovascular flow waveforms, with endothelial phenotype assessed by immunofluorescence and cytokine profiling. Flow initiation induced a transient inflammatory response, with elevated MCP-1 and TNF-α at day two, followed by a resolution of cytokine levels by day five, including a ∼7.5-fold reduction in MCP-1, despite increased haemodynamic loading. Endothelial cells retained a cobblestone-like morphology with eNOS undetected, resembling a partially activated phenotype. Compared with steady flow, cardiovascular flow reduced TGF-β1 and IL-8 secretion and decreased FGF-b consumption (∼2.5 fold), suggesting enhanced phenotypic stability. This study presents the first in vitro IA model incorporating a cardiovascular flow waveform and identifies cytokine signatures with potential utility as biomarkers of IA remodelling, highlighting the importance of long-term perfusion for modelling chronic vascular disease. Table of Contents Figure: An in vitro model of an intracranial aneurysm was developed to investigate how fluid flow dynamics impact endothelial remodelling and inflammation. Pulsatile cardiac flow promoted stabilisation of inflammatory signalling, which was sustained under a steady flow regime. Cytokine signatures emerged with potential utility as biomarkers of IA remodelling, highlighting the importance of long-term perfusion for modelling chronic vascular disease. The schematic of the cytokine release dynamics used in the graphical abstract below was generated with the assistance of AI-based tools including ChatGPT (v5.5) and M365 Copilot to align with key results from this manuscript.
Open AccessIdentifying cytokine-release signatures of flow-driven endothelial remodelling in an intracranial aneurysm cell culture model
Intracranial aneurysm (IA) rupture is catastrophic, yet current models of rupture-risk inadequately capture underlying IA remodelling mechanisms. Endothelial-haemodynamic interactions are central to these processes, but in vitro flow platforms often lack vessel-relevant geometry or long-term perfusion. Here, temporal and spatial endothelial responses to haemodynamic stress were investigated across idealised and patient-specific vascular models. Polydimethylsiloxane models were endothelialised with human aortic endothelial cells then perfused at up to 1.6 Pa wall shear stress for five days. IA models were exposed to steady or cardiovascular flow waveforms, with endothelial phenotype assessed by immunofluorescence and cytokine profiling. Flow initiation induced a transient inflammatory response, with elevated MCP-1 and TNF-α at day two, followed by a resolution of cytokine levels by day five, including a ∼7.5-fold reduction in MCP-1, despite increased haemodynamic loading. Endothelial cells retained a cobblestone-like morphology with eNOS undetected, resembling a partially activated phenotype. Compared with steady flow, cardiovascular flow reduced TGF-β1 and IL-8 secretion and decreased FGF-b consumption (∼2.5 fold), suggesting enhanced phenotypic stability. This study presents the first in vitro IA model incorporating a cardiovascular flow waveform and identifies cytokine signatures with potential utility as biomarkers of IA remodelling, highlighting the importance of long-term perfusion for modelling chronic vascular disease. Table of Contents Figure: An in vitro model of an intracranial aneurysm was developed to investigate how fluid flow dynamics impact endothelial remodelling and inflammation. Pulsatile cardiac flow promoted stabilisation of inflammatory signalling, which was sustained under a steady flow regime. Cytokine signatures emerged with potential utility as biomarkers of IA remodelling, highlighting the importance of long-term perfusion for modelling chronic vascular disease. The schematic of the cytokine release dynamics used in the graphical abstract below was generated with the assistance of AI-based tools including ChatGPT (v5.5) and M365 Copilot to align with key results from this manuscript.
- Open Access
- 13 April 2026
- Published by Wiley in Advanced Materials Technologies
- Vol. 11 (13)
Additive Manufacturing of Patient‐Specific Intracranial Aneurysm Cell Culture Models
Intracranial aneurysms (IAs) affect 2%–6% of the population, with rupture causing 30%–50% mortality and lifelong disabilities in survivors. Limited understanding of the mechanisms underlying IA rupture hinders the development of effective treatment guidelines. This study investigates additive manufacturing techniques to fabricate patient‐specific IA culture models for in vitro investigation of IA pathophysiology. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS), and collagen gel with immortalized human brain endothelial cells (HBECs) was investigated. Three fabrication methods were explored: digital light printing (DLP) of a water‐soluble sacrificial core embedded in PDMS, chocolate injection moulding of a sacrificial core embedded in PDMS, and stereolithography 3D printing. Models were cellularized and analyzed for geometric accuracy and distension. PDMS, collagen gel, and elastic50A resin supported over 95% cell viability with continued proliferation. All three methods produced basilar artery IA models with Dice‐Sørensen coefficients over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. Tunable wall thickness enabled localized distension under pressure, mimicking thin‐ and thick‐walled aneurysms. PDMS molded into IA geometries using DLP or chocolate injection moulding, enables high‐fidelity models suitable for cell culture, supporting future studies into the role of fluid shear and mechanical strain in IA rupture.
- 13 April 2026
- Published by Wiley in Advanced Materials Technologies
- Vol. 11 (13)
Open AccessAdditive Manufacturing of Patient‐Specific Intracranial Aneurysm Cell Culture Models
Intracranial aneurysms (IAs) affect 2%–6% of the population, with rupture causing 30%–50% mortality and lifelong disabilities in survivors. Limited understanding of the mechanisms underlying IA rupture hinders the development of effective treatment guidelines. This study investigates additive manufacturing techniques to fabricate patient‐specific IA culture models for in vitro investigation of IA pathophysiology. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS), and collagen gel with immortalized human brain endothelial cells (HBECs) was investigated. Three fabrication methods were explored: digital light printing (DLP) of a water‐soluble sacrificial core embedded in PDMS, chocolate injection moulding of a sacrificial core embedded in PDMS, and stereolithography 3D printing. Models were cellularized and analyzed for geometric accuracy and distension. PDMS, collagen gel, and elastic50A resin supported over 95% cell viability with continued proliferation. All three methods produced basilar artery IA models with Dice‐Sørensen coefficients over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. Tunable wall thickness enabled localized distension under pressure, mimicking thin‐ and thick‐walled aneurysms. PDMS molded into IA geometries using DLP or chocolate injection moulding, enables high‐fidelity models suitable for cell culture, supporting future studies into the role of fluid shear and mechanical strain in IA rupture.
- Open Access
Additive manufacturing of patient-specific intracranial aneurysm cell culture models
Intracranial aneurysms (IAs) are present in 2-6% of the global population. While rare, rupture results in mortality rates of 30-50% and lifelong disabilities in survivors. While treatment of unruptured IAs carries its own risk of mortality, there are no rigid guidelines indicating which IA presentation is at greater risk of rupture. We develop and evaluate the suitability of various additive manufacturing processes to fabricate patient-specific IA culture models for understanding IA pathophysiology and thereby support future development of a rupture risk prediction tool. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS) and collagen gel with immortalised human brain endothelial cells (HBECs) were investigated. Patient angiograms were segmented to produce in vitro models via two fabrication approaches: stereolithography (SLA) 3D printing versus chocolate injection moulding of a sacrificial core embedded in PDMS. These 3D arterial models were then cellularised with HBECs, and geometric accuracy and distension properties evaluated. PDMS, collagen gel and the elastic50A resin materials supported cellularisation on material surfaces with high cell viability and proliferation. Both the 3D printed resin and injection moulding techniques successfully fabricated patient-specific basilar artery IA models with a Dice-Sørensen coefficient of over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. This exceeds current benchmarks on IA fabrication accuracy. Through controlling IA model wall thickness, we demonstrate the ability to create localised distension under pressure in the context of thin– and thick-walled aneurysms. In vitro IA models present a promising platform for investigating IA pathophysiology and rupture risk. The novel chocolate sacrificial core technique offers a biocompatible, support-free fabrication method suitable for 3D cultures. Given the independent effects of fluid dynamics and mechanical strain on cell behaviour, it is essential to characterise distension under pressure and ensure accurate fabrication for reliable analysis into cell behaviour.
Open AccessAdditive manufacturing of patient-specific intracranial aneurysm cell culture models
Intracranial aneurysms (IAs) are present in 2-6% of the global population. While rare, rupture results in mortality rates of 30-50% and lifelong disabilities in survivors. While treatment of unruptured IAs carries its own risk of mortality, there are no rigid guidelines indicating which IA presentation is at greater risk of rupture. We develop and evaluate the suitability of various additive manufacturing processes to fabricate patient-specific IA culture models for understanding IA pathophysiology and thereby support future development of a rupture risk prediction tool. Material compatibility of several 3D printed resins, polydimethylsiloxane (PDMS) and collagen gel with immortalised human brain endothelial cells (HBECs) were investigated. Patient angiograms were segmented to produce in vitro models via two fabrication approaches: stereolithography (SLA) 3D printing versus chocolate injection moulding of a sacrificial core embedded in PDMS. These 3D arterial models were then cellularised with HBECs, and geometric accuracy and distension properties evaluated. PDMS, collagen gel and the elastic50A resin materials supported cellularisation on material surfaces with high cell viability and proliferation. Both the 3D printed resin and injection moulding techniques successfully fabricated patient-specific basilar artery IA models with a Dice-Sørensen coefficient of over 90%. However, only PDMS models offered complete cell coverage in 3D geometries. This exceeds current benchmarks on IA fabrication accuracy. Through controlling IA model wall thickness, we demonstrate the ability to create localised distension under pressure in the context of thin– and thick-walled aneurysms. In vitro IA models present a promising platform for investigating IA pathophysiology and rupture risk. The novel chocolate sacrificial core technique offers a biocompatible, support-free fabrication method suitable for 3D cultures. Given the independent effects of fluid dynamics and mechanical strain on cell behaviour, it is essential to characterise distension under pressure and ensure accurate fabrication for reliable analysis into cell behaviour.
- Open Access
- 30 May 2024
- Published by Springer Nature in Scientific Data
- Vol. 11 (1) , 1-10
Time-of-Flight MRA of Intracranial Aneurysms with Interval Surveillance, Clinical Segmentation and Annotations
Intracranial aneurysms (IAs) are present in 2–6% of the global population and can be catastrophic upon rupture with a mortality rate of 30–50%. IAs are commonly detected through time-of-flight magnetic resonance angiography (TOF-MRA), however, this data is rarely available for research and training purposes. The provision of imaging resources such as TOF-MRA images is imperative to develop new strategies for IA detection, rupture prediction, and surgical training. To support efforts in addressing data availability bottlenecks, we provide an open-access TOF-MRA dataset comprising 63 patients, of which 24 underwent interval surveillance imaging by TOF-MRA. Patient scans were evaluated by a neuroradiologist, providing aneurysm and vessel segmentations, clinical annotations, 3D models, in addition to 3D Slicer software environments containing all this data for each patient. This dataset is the first to provide interval surveillance imaging for supporting the understanding of IA growth and stability. This dataset will support computational and experimental research into IA dynamics and assist surgical and radiology training in IA treatment.
- 30 May 2024
- Published by Springer Nature in Scientific Data
- Vol. 11 (1) , 1-10
Open AccessTime-of-Flight MRA of Intracranial Aneurysms with Interval Surveillance, Clinical Segmentation and Annotations
Intracranial aneurysms (IAs) are present in 2–6% of the global population and can be catastrophic upon rupture with a mortality rate of 30–50%. IAs are commonly detected through time-of-flight magnetic resonance angiography (TOF-MRA), however, this data is rarely available for research and training purposes. The provision of imaging resources such as TOF-MRA images is imperative to develop new strategies for IA detection, rupture prediction, and surgical training. To support efforts in addressing data availability bottlenecks, we provide an open-access TOF-MRA dataset comprising 63 patients, of which 24 underwent interval surveillance imaging by TOF-MRA. Patient scans were evaluated by a neuroradiologist, providing aneurysm and vessel segmentations, clinical annotations, 3D models, in addition to 3D Slicer software environments containing all this data for each patient. This dataset is the first to provide interval surveillance imaging for supporting the understanding of IA growth and stability. This dataset will support computational and experimental research into IA dynamics and assist surgical and radiology training in IA treatment.